Abstract

Summary

This study demonstrates that introducing halorhodopsin (a light-sensitive protein) into dormant cone photoreceptors can restore visual function in retinitis pigmentosa mouse models and human ex vivo retinas, offering a potential therapeutic pathway for a currently incurable blinding disease. For clinical and lighting-adjacent applications, the findings suggest that patients with residual but non-functional cones may be candidates for optogenetic vision restoration, which could eventually inform how lighting environments are designed to support patients with partial retinal function.
Abstract

Key Findings

  • Halorhodopsin expression in light-insensitive cones restored light sensitivity and activated all retinal cone pathways in mouse models of retinitis pigmentosa.
  • Resensitized cones were capable of driving complex retinal circuit functions including directional selectivity, activating cortical circuits, and mediating visually guided behaviors.
  • Human ex vivo retinas from blind patients with persisting light-insensitive cones were successfully reactivated using halorhodopsin, identifying a viable patient population for this therapy.
  • The approach bypassed the native phototransduction cascade entirely, demonstrating that archaebacterial opsins can functionally substitute for degenerated mammalian photoreceptor machinery.
Categories

Categories

Eye Health & Vision: Directly addresses retinitis pigmentosa, a hereditary retinal degenerative disease causing blindness, and presents a gene therapy approach to restore photoreceptor function.
The Science of Light: Investigates photoreceptor biology and phototransduction mechanisms, using archaebacterial halorhodopsin as a substitute opsin to restore light sensitivity in degenerated cone photoreceptors.
Authors

Author(s)

V Busskamp, J Duebel, D Balya, M Fradot, TJ Viney
Publication Date

Publication Year

2010
Citations

Number of Citations

732
View more publications